Closed-Loop Drug Administration Control System

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Closed-loop control systems for anesthesia face challenges in addressing significant intra- and inter-patient variability in response to standard drug doses, leading to safety concerns and inefficiencies in drug delivery.

Innovation Solution

The implementation of a Model Predictive Controller (MPC) with auxiliary models, such as population-based PKPD models, to constrain drug infusion rates and concentrations, ensuring safe and effective anesthesia delivery by integrating physiological characteristics like blood pressure and depth of hypnosis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If manual adjustment of drug dosing is used to account for patient variability, then individualized anesthesia can be achieved, but it requires considerable clinical experience and increases the complexity of operation

Engineering Contradiction:
Improveindividualized drug infusionVSAvoidmanual adjustment complexity
Core Design Contradiction:
Adaptability or versatilityVSEase of operation

Solution Approach 1:

The closed-loop control system automatically adjusts drug infusion rates based on real-time physiological feedback without requiring continuous manual intervention. The system self-regulates by comparing actual physiological parameters against target values and automatically modifying the infusion rate to maintain optimal anesthesia depth, thereby eliminating the need for constant clinical assessment and adjustment while achieving individualized anesthesia.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system continuously monitors physiological parameters (such as BIS, heart rate, blood pressure) and uses this feedback to automatically adjust drug infusion rates. The feedback loop enables the system to detect deviations from the desired anesthesia depth and correct them in real-time, providing adaptability without requiring manual intervention and reducing operational complexity.

Inventive Principle:
Principle #23Feedback

2Ease of operation

If fixed drug infusion rates are used based on patient body weight, then the system is simple to operate, but it does not account for individual patient response variability

Engineering Contradiction:
Improvefixed infusion rate simplicityVSAvoidpatient response variability
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The system transitions from a static fixed infusion rate approach to a dynamic adaptive control system. The infusion rate is continuously adjusted based on real-time physiological feedback, allowing the system to adapt to individual patient responses while maintaining ease of operation through automated control. The dynamic adjustment occurs without requiring complex manual programming by the clinician.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system automatically modifies the drug infusion rate parameter based on physiological feedback and patient response. Instead of using a fixed parameter value, the system dynamically changes the infusion rate to optimize anesthesia depth for each individual patient, achieving adaptability while the automated nature maintains operational simplicity.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If closed-loop control is implemented to reduce patient variability, then drug delivery precision is improved, but system complexity increases

Engineering Contradiction:
Improvedrug delivery precisionVSAvoidcontrol system complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The closed-loop control system integrates multiple functions into a single automated platform: physiological parameter monitoring, target anesthesia depth calculation, real-time feedback processing, and automatic infusion rate adjustment. This multi-functionality achieves precise drug delivery while consolidating complexity into an integrated system that requires minimal external intervention, balancing precision with manageable system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Reliability

If higher drug infusion rates are used to ensure adequate anesthesia, then anesthesia depth is improved, but the risk of overdose and harmful effects increases

Engineering Contradiction:
Improveanesthesia depth assuranceVSAvoidoverdose risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system continuously monitors physiological parameters that indicate anesthesia depth and uses this feedback to adjust the infusion rate. By detecting when the desired anesthesia depth is achieved, the system automatically reduces the infusion rate to prevent overdose, thereby ensuring reliable anesthesia depth while minimizing harmful effects through real-time feedback-based dose optimization.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system proactively prevents overdose by continuously monitoring physiological parameters and adjusting the infusion rate before harmful effects can occur. The feedback mechanism detects early signs of excessive anesthesia depth and automatically reduces the dose in advance, counteracting potential harm before it manifests, thus ensuring safety while maintaining adequate anesthesia.

Inventive Principle:
Principle #9Preliminary anti-action

Data Source

PatentUS20240216610A1Methods and systems for closed-loop control of drug administration
Publication Date: 2024.07.04 THE UNIV OF BRITISH COLUMBIA
  • US20240216610A1 patent drawing
  • US20240216610A1 patent drawing
  • US20240216610A1 patent drawing

AI summary

A control system for administration of a drug comprises a drug administration actuator for administering the drug to a patient at a controllable dosage; a monitor for measuring an effect of the drug on the patient; and a controller configured to determine a control signal to the drug administration actuator; wherein the controller is configured to implement a closed loop model-predictive control scheme comprising, for each of a series of time steps, minimizing a cost function subject to one or more constraints to determine the control signal, the cost function based at least in part on a reference level and the monitor measurement; wherein the control signal is used as an input to an auxiliary model to estimate at least one concentration level of the drug in the patient; and wherein the constraints comprise at least one constraint on the estimate of the concentration level of the drug.